Bibliography
Rodriguez-Feo, J. A., Hellings, W. E., Moll, F. L., De Vries, J.-P. P. M., van Middelaar, B. J., Algra, A., Sluijter, J., Velema, E., van der Broek, T., Sessa, W. C., De Kleijn, D. P. V., & Pasterkamp, G. (2008). Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease. PLoS ONE, 3(7), e2612.
Authors
12
- Juan A. Rodriguez-Feo (first)
- Willem E. Hellings (additional)
- Frans L. Moll (additional)
- Jean-Paul P. M. De Vries (additional)
- Ben J. van Middelaar (additional)
- Ale Algra (additional)
- Joost Sluijter (additional)
- Evelyn Velema (additional)
- Theo van der Broek (additional)
- William C. Sessa (additional)
- Dominique P. V. De Kleijn (additional)
- Gerard Pasterkamp (additional)
References
39
Referenced
32
10.1161/01.CIR.92.3.657
/ Circulation / Coronary plaque disruption. by E Falk (1995)10.1016/j.jvs.2005.08.009
/ J Vasc Surg / Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. by B Verhoeven (2005)10.1056/NEJM199705013361802
/ N Engl J Med / Coronary risk factors and plaque morphology in men with coronary disease who died suddenly by AP Burke (1997)10.1056/NEJMra043430
/ N Engl J Med / Inflammation, atherosclerosis, and coronary artery disease. by GK Hansson (2005)10.1172/JCI117619
/ J Clin Invest / Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. by ZS Galis (1994)10.1016/j.cardiores.2005.11.026
/ Cardiovasc Res / Vascular remodeling and protease inhibition–bench to bedside. by JP Sluijter (2006)10.1056/NEJM199705013361802
/ N Engl J Med / Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. by AP Burke (1997)10.1007/s10564-004-2304-6
/ Eur J Epidemiol / Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. by BA Verhoeven (2004)10.1016/j.tcm.2007.03.006
/ Trends Cardiovasc Med / From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. by WE Hellings (2007)10.1161/01.RES.0000129178.56294.17
/ Circ Res / Caveolae and caveolins in the cardiovascular system. by JP Gratton (2004)10.2174/138161207780831202
/ Curr Pharm Des / Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease. by PG Frank (2007)10.1097/00041433-200410000-00005
/ Curr Opin lipidol / Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. by PG Frank (2004)10.1161/01.ATV.0000101182.89118.E5
/ Arterioscler Thromb Vasc Biol / Genetic ablation of caveolin-1 confers protection against atherosclerosis. by PG Frank (2004)10.1021/bi049609t
/ Biochemistry / Caveolin-1 deficiency stimulates neointima formation during vascular injury. by GS Hassan (2004)10.1369/jhc.5A6869.2006
/ J Histochem Cytochem / Caveolin-1 expression is associated with plaque formation in hypercholesterolemic rabbits by WW Lin (2006)10.1016/j.cardiores.2005.05.004
/ Cardiovasc Res / Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. by C Schwencke (2005)10.1056/NEJM199108153250701
/ N Engl J Med / Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. (1991)10.1016/S0140-6736(97)09292-1
/ Lancet / Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). (1998)10.1016/S0140-6736(04)16146-1
/ Lancet / Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. by A Halliday (2004)10.1016/j.jvs.2007.08.018
/ J Vasc Surg / Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. by WE Hellings (2007)10.1161/01.STR.0000196986.50059.e0
/ Stroke / Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. by JP Sluijter (2006)10.1161/01.ATV.0000058404.92759.32
/ Arterioscler Thromb Vasc Biol / Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms by MW Manning (2003)10.1161/01.CIR.0000032146.75113.EE
/ Circulation / In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. by A Vink (2002)10.1038/82176
/ Nat Med / In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. by M Bucci (2000)10.1016/S1535-6108(03)00168-5
/ Cancer Cell / Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. by JP Gratton (2003)10.1161/01.CIR.0000109140.51366.72
/ Circulation / Toll-like receptor 4 is involved in outward arterial remodeling. by SC Hollestelle (2004)10.1016/S0014-5793(01)02622-9
/ FEBS Lett / Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling. by DP de Kleijn (2001)10.1161/01.ATV.0000120376.09047.fe
/ Arterioscler Thromb Vasc Biol / Expansive arterial remodeling: location, location, location. by G Pasterkamp (2004)10.1136/hrt.82.4.461
/ Heart / Coronary artery disease: arterial remodelling and clinical presentation. by PC Smits (1999)10.1177/00220345870660080401
/ J Dent Res / A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. by LM Golub (1987)10.1016/j.yjmcc.2007.01.008
/ J Mol Cell Cardiol / Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. by AK Chow (2007)10.1091/mbc.E04-05-0402
/ Mol Biol Cell / Links between CD147 function, glycosylation, and caveolin-1. by W Tang (2004)10.1074/jbc.M312947200
/ J Biol Chem / Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. by W Tang (2004)10.1006/jsre.1999.5707
/ J Surg Res / Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456. by JK Karwowski (1999)10.1165/rcmb.2005-0376OC
/ Am J Respir Cell Mol Biol / Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. by XM Wang (2006)10.1016/j.lfs.2004.03.004
/ Life Sci / Caveolin-1, Id3a and two LIM protein genes are upregulated by estrogen in vascular smooth muscle cells. by T Watanabe (2004)10.1016/j.jvs.2006.09.051
/ J Vasc Surg / Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. by WE Hellings (2007)10.1016/S0140-6736(99)04470-0
/ Lancet / Evidence of a chronic systemic cause of instability of atherosclerotic plaques. by PM Rothwell (2000)10.1161/CIRCULATIONAHA.106.634709
/ Circulation / Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy by JF Jasmin (2006)
Dates
Type | When |
---|---|
Created | 17 years, 1 month ago (July 1, 2008, 6:44 p.m.) |
Deposited | 5 years, 3 months ago (May 9, 2020, 2:15 a.m.) |
Indexed | 3 months, 3 weeks ago (May 6, 2025, 6:35 p.m.) |
Issued | 17 years, 1 month ago (July 2, 2008) |
Published | 17 years, 1 month ago (July 2, 2008) |
Published Online | 17 years, 1 month ago (July 2, 2008) |
@article{Rodriguez_Feo_2008, title={Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease}, volume={3}, ISSN={1932-6203}, url={http://dx.doi.org/10.1371/journal.pone.0002612}, DOI={10.1371/journal.pone.0002612}, number={7}, journal={PLoS ONE}, publisher={Public Library of Science (PLoS)}, author={Rodriguez-Feo, Juan A. and Hellings, Willem E. and Moll, Frans L. and De Vries, Jean-Paul P. M. and van Middelaar, Ben J. and Algra, Ale and Sluijter, Joost and Velema, Evelyn and van der Broek, Theo and Sessa, William C. and De Kleijn, Dominique P. V. and Pasterkamp, Gerard}, editor={Schmidt, Harald H. H. W.}, year={2008}, month=jul, pages={e2612} }